Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: china

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Usage    : Acarbose is a novel oral hypoglycemic agents. In the intestine of competitive inhibition of glycoside hydrolase. Reduce the polysaccharide and sucrose into glucose, the sugar uptake corresponding to slow down, so it can be with the postprandial blood glucose lowering effect. Generally used alone, or with other oral hypoglycemic agents or insulin therapy. With the food and beverage, treatment of insulin dependent and non dependent diabetes mellitus. Acarbose for carbohydrates in the small intestine and is absorbed slow decomposition, prolong the retention time, the intestinal bacteria glycolysis and gas production increased, so it can cause abdominal distension, abdominal pain and diarrhea

Send your message to this supplier
  • From:
  • To:
    Qingdao Qingmei Biotech Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service